Our analyses revealed the enhanced enrichment of NF-κB and AP-1 TF footprints genome-wide in both TWEAK/Fn14 activated TNBC cell lines and Fn14-high TNBC tumours (Fig. 4a, b, Supplementary Fig. 10). The gene discussed is TNFRSF12A; the disease is neoplasm.